As has been the case with other high-profile cabinet picks, Donald Trumpappears to be considering at least one figure who is highlyunconventional and distrusted by the establishment for the head ofthe FDA.

NBC reports Trump is pondering Jim O’Neill, who isa longtime colleague of PayPal billionaire Peter Thiel, a majorTrump backer. O’Neill, like Thiel, describes himself as alibertarian and has said the FDA should have far less ability torestrict new drugs from entering the market before their safety andeffectiveness has been judged.

Even the pharmaceutical industry would likely be skeptical of avehemently anti-regulation FDA chief, says Michael Gaba, who workson health care policy for Holland & Knight, in an interviewwith NBC.

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

  • Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and events
  • Access to other award-winning ALM websites including and

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.